Capstan Medical (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- December 12, 2024
- Vertical
- Medical Devices
- Funding URL
- View Funding Page
- Funding Amount:
- $110,000,000
Company Info
- Founding Year
- 2020
- Traction
- Capstan is preparing for first-in-human trials in early 2025 and has raised $31.4 million in a previous financing round.
- Company Description
- Capstan Medical is developing heart valve implants with a robotic delivery platform, focusing on minimally invasive solutions for mitral and tricuspid valve regurgitation.
- Market
- Cardiac
- Location
- Santa Cruz, California, USA
- Coinvestors
- Eclipse, Yu Galaxy, Intuitive Ventures, Gideon Strategic Partners